ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Molecular Partners AG

Molecular Partners AG (MOLN)

4.11
0.40
(10.78%)
終了 6月14日 5:00AM
3.91
-0.20
(-4.87%)
取引時間後: 8:59AM

Molecular Partners AG (MOLN) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
4.11
( 10.78% )
買値
2.72
売値
4.59
出来高
1,850
3.74 日の範囲 4.11
3.4101 52 週間の範囲 5.36
時価総額
前日終値
3.71
始値
3.74
時刻
1
@
3.75
最終取引時間
財務取引量
US$ 7,604
VWAP
4.11
平均取引量 (3 か月)
US$ 29,761
発行済株式数
37,511,163
配当利回り
PER
-1.94
1 株当たり利益 (EPS)
-1.55
歳入
-
純利益
-58.02M

Molecular Partners AG について

Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 2 clinical trial for the treatment of advanced solid tumor... Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in Phase 1 clinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and MP0726, a Radio-DARPin Therapy to treat ovarian cancer and other MSLNexpressing cancers. In addition, the company develops MP0621, a Switch-DARPin candidate targeting CD16a, c-KIT, and CD47 as conditioning for hematopoietic stem cell transplantation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates and Eckert & Ziegler SE to develop Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Schlieren, Switzerland
設立
2026
Molecular Partners AG is listed in the Healthcare sector of the ナスダック市場 with ticker MOLN. The last closing price for Molecular Partners was US$3.71. Over the last year, Molecular Partners shares have traded in a share price range of US$ 3.4101 to US$ 5.36.

Molecular Partners currently has 37,511,163 shares in issue. The market capitalisation of Molecular Partners is US$154.17 million. Molecular Partners has a price to earnings ratio (PE ratio) of -1.94.

MOLN 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.0350.8588957055214.0754.113.6731753.88196044DR
40.359.30851063833.764.34593.6661043.90481553DR
12-0.57-12.17948717954.684.72253.6641734.04323751DR
26-0.32-7.223476297974.435.363.6644424.2127244DR
520.369.63.755.363.410141034.0965828DR
156-2.65-39.2011834326.7612.73.3298575.703057DR
260-15.89-79.452032.043.321630013.11181448DR

MOLN - Frequently Asked Questions (FAQ)

What is the current Molecular Partners AG share price?
The current share price of Molecular Partners AG is US$ 4.11
How many Molecular Partners AG shares are in issue?
Molecular Partners AG has 37,511,163 shares in issue
What is the market cap of Molecular Partners AG?
The market capitalisation of Molecular Partners AG is USD 154.17M
What is the 1 year trading range for Molecular Partners AG share price?
Molecular Partners AG has traded in the range of US$ 3.4101 to US$ 5.36 during the past year
What is the PE ratio of Molecular Partners AG?
The price to earnings ratio of Molecular Partners AG is -1.94
What is the registered address of Molecular Partners AG?
The registered address for Molecular Partners AG is Wagistrasse 14, Schlieren, Zurich, 8952
What is the Molecular Partners AG website address?
The website address for Molecular Partners AG is www.molecularpartners.com
Which industry sector does Molecular Partners AG operate in?
Molecular Partners AG operates in the Biotechnology & Life Sciences sector

MOLN 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

MOLN Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock